HICKSVILLE,
NY, -- January 30, 2020 -- InvestorsHub NewsWire -- Canbiola, Inc.
(OTCQB: CANB) (“Canbiola”
or the “Company”), a diversified health and wellness company
specializing in the highest grade CBD products on the market,
announced today the signing of an exclusive license agreement with
Lifeguard Licensing Corp. for the use of the well-known LifeGuard™
brand name and logo for a host of products that will include CBD
and non-CBD formulations.
The license covers the
United States, its territories and possessions, Canada and Mexico.
The term is for 5 years with extensions at each five-year
anniversary initially until 2035.
The license will allow
Canbiola to produce and sell a wide range of products. Wellness
products will include lip care products such as balms,
moisturizers, cold-sore, and topical pain relief products such as
salves, sprays, and gels for sunburn relief, rashes, abrasions, and
similar products. Consumable products will include energy shots,
gummy bears and candy, cookies and pastry type products; it will
also include beverages such as fruit-based drinks, protein type
drinks, carbonated type drinks, and similar products and alcohol
based drinks such as beer, hard alcohol, wine and similar. Each and
all products may or may not contain CBD and maybe for animals
(pets) or human use or consumption.
“The signing of this
license agreement with a globally recognized brand, LifeGuard™,
allows our company to introduce an array of new products, both
traditional and CBD based, under an iconic label that is instantly
recognized the world over,” said Marco Alfonsi, CEO. “The iconic
red background with a white cross and LifeGuard™ name symbolizes
safety, integrity, and well-being. The company will initially be
launching a full line of sunblocks, tanning lotions, after sun
care, lip balms, and a unique formulation to replenish the body
after an active day either at work, the gym, the beach, or the
slopes!”
About Canbiola,
Inc.
Canbiola is a Health &
Wellness company dedicated to delivering the highest quality CBD
products, Nutritionals, consumer products, and related medical
equipment. Products are sold to consumers online, via retailers,
marketing partners, events, and through doctors and other medical
and health & wellness organizations. Our products are designed,
grown, and produced to the highest industry standards to promote
wellness and reduce pain, inflammation, anxiety, sleep disorders,
and related issues. Further, we are committed to serving our
customers and marketing partners, with not only the best products
but the best service and experience in the marketplace now and in
the future.
Canbiola owns and operates
a manufacturing facility under Pure Health Products in Lacey,
Washington where all CBD based products are blended and packaged.
Canbiola owns and operates Duramed Inc, which sells medical
supplies and devices. Canbiola owns and operates NY Hemp Depot and
Green Grow Farms, which are licensed to grow and cultivate Hemp in
the State of New York.
For more information about
Canbiola, Inc., please visit: Canbiola.com
Forward-Looking
Statements
Forward-looking statements
and risks and uncertainties discussed in this letter contain
forward-looking statements. The words "anticipate," "believe,"
"estimate," "may," "intend," "expect," and similar expressions
identify such forward-looking statements. Expected, actual results,
performance, or achievements could differ materially from those
contemplated, expressed, or implied by the forward-looking
statements contained herein. Forward-looking statements are subject
to a number of risks and uncertainties, including but not limited
to, risks and uncertainties associated with, among other things,
the impact of economic, competitive, and other factors affecting
our operations, markets, products, and performance. The matters
discussed herein should not be construed in any way, shape or
manner of our future financial condition or stock
price.
Follow Canbiola
on:
Twitter
@CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd
or @canbiola_medical_cbd
Follow us on
Facebook
Investors and Media:
IR@canbiola.com
(646) 397-2309